Management of the androgen-deficient woman

Growth Hormone and IGF Research

Volumn 13, Issue SUPPL. A, 2003, Pages

  Arlt, Wiebke ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Androgen deficiency; Androgen replacement; Dehydroepiandrosterone (DHEA); Dehydroepiandrosterone sulfate; Female androgen deficiency syndrome

Indexed keywords

ANDROGEN; ESTROGEN; GESTAGEN; GLUCOCORTICOID; METHYLTESTOSTERONE; OXANDROLONE; PRASTERONE; TESTOSTERONE DERIVATIVE; TESTOSTERONE UNDECANOATE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ANDROGEN SYNTHESIS; ANDROGEN THERAPY; ARTICLE; BONE DENSITY; CLIMACTERIUM; CLINICAL TRIAL; DRUG ACTIVITY; DRUG HALF LIFE; DYSTHYMIA; FEMALE; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; HYPOPITUITARISM; LIBIDO; MENOPAUSE; MOOD; OVARY; OVARY INSUFFICIENCY; POSTMENOPAUSE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0141520289     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00060-1     Document Type: Article

References (33)

1. W. Arlt, B. Allolio, Dehydroepiandrosterone replacement therapy, Curr. Opin. Endocrinol. Diab. 8 (2001) 130-139.
2. R.V. Haning Jr., C.W. Austin, I.H. Carlson, D.L. Kuzma, W.J. Zweibel, Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis, Obstet. Gynecol. 65 (1985) 199-205.
3. W. Arlt, H.-G. Justl, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H.M. Schulte, B. Allolio, Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression, J. Clin. Endocrinol. Metab. 83 (1998) 1928-1934.
4. N. Orentreich, J.L. Brind, R.L. Rizer, J.H. Vogelman, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J. Clin. Endocrinol. Metab. 59 (1984) 551-555.
5. N. Orentreich, J.L. Brind, J.H. Vogelman, R. Andres, H. Baldwin, Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men, J. Clin. Endocrinol. Metab. 75 (1992) 1002-1004.
6. B. Couzinet, G. Meduri, M.G. Lecce, J. Young, S. Brailly, H. Loosfelt, E. Milgrom, G. Schaison, The postmenopausal ovary is not a major androgen-producing gland, J. Clin. Endocrinol. Metab. 86 (2001) 5060-5066.
7. K.K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, A. Klibanski, Androgen deficiency in women with hypopituitarism, J. Clin. Endocrinol. Metab. 86 (2001) 561-567.
8. H.G. Burger, Androgen production in women, Fertil. Steril. 77 (Suppl. 4) (2002) 3-5.
9. G.A. Laughlin, E. Barrett-Connor, D. Kritz- Silverstein, D. von Muhlen, Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study, J. Clin. Endocrinol. Metab. 85 (2000) 645-651.
10. C. Hojbjerg Gravholt, B. Svenstrup, P. Bennett, J. Sandahl Christiansen, Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status, Clin. Endocrinol. (Oxf.) 50 (1999) 791-800.
11. J. Bancroft, E.H. Cawood, Androgens and the menopause; a study of 40-60-year-old women, Clin. Endocrinol. (Oxf.) 45 (1996) 577-587.
12. L.S. Myers, J. Dixen, D. Morrissette, M. Carmichael, J.M. Davidson, Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women, J. Clin. Endocrinol. Metab. 70 (1990) 1124-1131.
13. H.M. Buckler, W.R. Robertson, F.C. Wu, Which androgen replacement therapy for women?, J. Clin. Endocrinol. Metab. 83 (1998) 3920-3924.
14. J.L. Shifren, G.D. Braunstein, J.A. Simon, P.R. Casson, J.E. Buster, G.P. Redmond, R.E. Burki, E.S. Ginsburg, R.C. Rosen, S.R. Leiblum, K.E. Caramelli, N.A. Mazer, K.P. Jones, C.A. Daugherty, Transdermal testosterone treatment in women with impaired sexual function after oophorectomy, N. Engl. J. Med. 343 (2000) 682-688.
15. J.L. Ross, D. Roeltgen, G.A. Stefanatos, P. Feuillan, H. Kushner, C. Bondy, G.B. Cutler Jr., Androgen-responsive aspects of cognition in girls with Turner syndrome, J. Clin. Endocrinol. Metab. 88 (2003) 292-296.
16. J.A. Kemppainen, E. Langley, C.I. Wong, K. Bobseine, W.R. Kelce, E.M. Wilson, Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone, Mol. Endocrinol. 13 (1999) 440-454.
17. B. Allolio, W. Arlt, DHEA treatment: myth or reality?, Trends Endocrinol. Metab. 13 (2002) 288.
18. J. Young, B. Couzinet, K. Nahoul, S. Brailly, P. Chanson, E.E. Baulieu, G. Schaison, Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans, J. Clin. Endocrinol. Metab. 82 (1997) 2578-2585.
19. W. Arlt, F. Callies, J.C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier, D. Huebler, M. Oettel, M. Ernst, H.M. Schulte, B. Allolio, Dehydroepiandrosterone replacement in women with adrenal insufficiency, N. Engl. J. Med. 341 (1999) 1013-1020.
20. J. Parasrampuria, K. Schwartz, R. Petesch, Quality control of dehydroepiandrosterone dietary supplement products, JAMA 280 (1998) 1565.
21. J.C. Montgomery, M. Brincat, A. Tapp, L. Appleby, E. Versi, P.B.C. Fenwick, J.W.W. Studd, Effect of oestrogen and testosterone implants on psychological disorders in the climacteric, Lancet 1 (1987) 297-299.
22. S.R. Davis, P. McCloud, B.J. Strauss, H. Burger, Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality, Maturitas 21 (1995) 227-236.
23. E. Barrett-Connor, R. Young, M. Notelovitz, J. Sullivan, B. Wiita, H.-M. Yang, J. Nolan, A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles, J. Reprod. Med. 44 (1999) 1012-1020.
24. J.C. Lovejoy, G.A. Bray, M.O. Bourgeois, R. Macchiavelli, J.C. Rood, C. Greeson, C. Partington, Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - a clinical research center study, J. Clin. Endocrinol. Metab. 81 (1996) 2198-2203.
25. A.S. Dobs, T. Nguyen, C. Pace, C.P. Roberts, Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women, J. Clin. Endocrinol. Metab. 87 (2002) 1509-1516.
26. H.M. Buckler, K. McElhone, P.N. Durrington, M.I. Mackness, C.A. Ludlam, F.C. Wu, The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women, Clin. Endocrinol. (Oxf.) 49 (1998) 173-178.
27. B.B. Sherwin, M.M. Gelfand, W. Brender, Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause, Psychosom. Med. 47 (1985) 339-351.
28. B.B. Sherwin, M.M. Gelfand, Sex steroids and affect in the surgical menopause: a double-blind, cross-over study, Psychoneuroendocrinology 10 (1985) 325-335.
29. K. Lovas, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison's disease, Clin. Endocrinol. (Oxf.) 56 (2002) 581-588.
30. P.J. Hunt, E.M. Gurnell, F.A. Huppert, C. Richards, A.T. Prevost, J.A. Wass, J. Herbert, V.K. Chatterjee, Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial, J. Clin. Endocrinol. Metab. 85 (2000) 4650-4656.
31. G. Johannsson, P. Burman, L. Wiren, B.E. Engstrom, A.G. Nilsson, M. Ottosson, B. Jonsson, B.A. Bengtsson, F.A. Karlsson, Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial, J. Clin. Endocrinol. Metab. 87 (2002) 2046-2052.
32. M. Bloch, P.J. Schmidt, M.A. Danaceau, L.F. Adams, D.R. Rubinow, Dehydroepiandrosterone treatment of midlife dysthymia, Biol. Psychiatry 45 (1999) 1533-1541.
33. K.T. Barnhart, E. Freeman, J.A. Grisso, D.J. Rader, M. Sammel, S. Kapoor, J.E. Nestler, The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life, J. Clin. Endocrinol. Metab. 84 (1999) 3896-3902.